Acrivon Therapeutics Stock Forecast

Buy or Hold candidate since Nov 10, 2025 Gain 17.24%

The Acrivon Therapeutics, Inc. stock price gained 6.25% on the last trading day (Monday, 17th Nov 2025), rising from $2.24 to $2.38. During the last trading day the stock fluctuated 11.71% from a day low at $2.22 to a day high of $2.48. The price has been going up and down for this period, and there has been a 2.15% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 155 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $3.19 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 58.52% during the next 3 months and, with a 90% probability hold a price between $3.12 and $3.99 at the end of this 3-month period.

ACRV Signals & Forecast

Mostly positive signals in the chart today. The Acrivon Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.14 and $1.98. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, November 07, 2025, and so far it has risen 26.60%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Acrivon Therapeutics, Inc. stock

Acrivon Therapeutics, Inc. finds support from accumulated volume at $2.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.260 between high and low, or 11.71%. For the last week, the stock has had daily average volatility of 11.33%.

Our recommended stop-loss: $2.29 (-3.78%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (ACRV) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Acrivon Therapeutics, Inc. to open at $2.36, and during the day (based on 14 day Average True Range), to move between $2.28 and $2.48, which gives a possible trading interval of +/-$0.194 (+/-8.49%) up or down from last closing price. If Acrivon Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.49% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $2.33, some $0.0500 (2.10%) from the current price of $2.38, our system finds the risk reward attractive.

Is Acrivon Therapeutics, Inc. stock A Buy?

Acrivon Therapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 6.558 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $2.36 ( 0.84%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk